bioAffinity Technologies, Inc. Finite-Lived Intangible Assets, Accumulated Amortization
bioAffinity Technologies, Inc. (BIAF) had Finite-Lived Intangible Assets, Accumulated Amortization of $162.36 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-08-07
- 2026-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $162.36K.
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $147.78K.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $133.19K.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $118.61K.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2026-06-30 | $162.36K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $147.78K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $133.19K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $118.61K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $104.03K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $89.44K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $74.86K 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$60.28K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$45.69K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$31.11K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $16.53K 10-K · filed 2025-03-31 | -$16.53K 10-K · filed 2024-04-01 |
| 2023-09-30 | -$1.94K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |